Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis

Annals of the Rheumatic Diseases

Volumn 68, Issue 4, 2009, Pages 595-598

  Harvey, D ^a   Pointon, J J ^a   Sleator, C ^b   Meenagh, A ^b   Farrar, C ^a   Sun, J Y ^c   Senitzer, D ^c   Middleton, D ^b   Brown, M A ^a,d   Wordsworth, B P ^a,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c City of Hope National Medical Centre   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; KIR3DL1 PROTEIN, HUMAN; KIR3DL2 PROTEIN, HUMAN;

ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ASSESSMENT; CONTROL GROUP; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; UNITED KINGDOM; ALLELE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; GENETICS; HAPLOTYPE; METHODOLOGY; POLYMERASE CHAIN REACTION; RISK;

ALLELES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; ODDS RATIO; POLYMERASE CHAIN REACTION; RECEPTORS, KIR; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DL2; RECEPTORS, KIR3DS1; RISK; SPONDYLITIS, ANKYLOSING;

EID: 65249162792     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.095927     Document Type: Article

References (15)

1. Carter KW, Pluzhnikov A, Timms AE, Miceli-Richard C, Bourgain C, Wordsworth BP, et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology 2007;46:763-71.
2. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001;193:1159-67.
3. Williams F, Meenagh A, Sleator C, Cook D, Fernandez-Vina M, Bowcock AM, et al. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 2005;66:836-41.
4. Allen RL, O'Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999;162:5045-8.
5. Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, et al. Cellsurface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002;46:2972-82.
6. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995;181:1133-44.
7. Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ. Leukocyte receptor complexencoded immunomodulatory receptors show differing specificity for alternative HLAB27 structures. J Immunol 2001;167:5543-7.
8. Chan AT, Kollnberger SD, Wedderburn LR, Bowness P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum 2005;52:3586-95.
9. Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez- Alvarez B, Pruneda L, et al. Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 2006;8:R101.
10. Brown MA, Pile KD, Kennedy LG, Calin A, Darke C, Bell J, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70.
11. Sun JY, Gaidulis L, Miller MM, Goto RM, Rodriguez R, Forman SJ, et al. Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 2004;64:462-8.
12. Meenagh A, Williams F, Sleator C, Halfpenny IA, Middleton D. Investigation of killer cell immunoglobulin-like receptor gene diversity V. KIR3DL2. Tissue Antigens 2004;64:226-34.
13. Single RM, Martin MP, Gao X, Meyer D, Yeager M, Kidd JR, et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 2007;39:1114-19.
14. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997;7:739-51.
15. Gumperz JE, Valiante NM, Parham P, Lanier LL, Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J Exp Med 1996;183:1817-27.